Refractory Focal Onset Epilepsy - Biohaven BHV7000-201

Refractory Focal Onset Epilepsy – Biohaven BHV7000-201

Participating in a clinical trial with Profound means making a real difference in the lives of others facing similar health challenges.

A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy

Key Inclusion Criteria:

Subjects who completed the double-blind phase (DBP) of prior parent study, BHV7000-302 or BHV7000-303.
(FOCBP) Females of Child Bearing Potential must have a negative urine pregnancy test at the Baseline/Day 0 visit
Other criteria may apply

Complete the form and our team will reach out soon to help determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

How did you hear about us?

Other (Please specify)

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Refractory Focal Onset Epilepsy – Biohaven BHV7000-201